eClinical Solutions

“To move in the direction the FDA is suggesting, you need not just a unified infrastructure but an integrated approach to data review, quality, and risk management.” In a recent Q&A article, eClinical Solutions CEO Raj Indupuri shares: ✦ What the FDA's push toward continuous data review actually demands of sponsors operationally ✦ Why fragmented systems are the core obstacle ✦ How AI and real-world evidence fit into a more data-driven regulatory environment Read the article from Andy Studna at Applied Clinical Trials: https://lnkd.in/gjhzjj69

📢 Announcing the keynote speaker of #ENGAGE2026... 👇👇👇 Elin Haf Davies! Dr. Elin Haf Davies has spent nearly two decades advancing treatments for children with rare diseases. After earning her PhD in Neurometabolic Disorders, she founded Aparito, a digital health company that pioneered the use of digital biomarkers and remote patient monitoring in clinical research.   Beyond her work in life sciences, she's spent more than 200 days at sea, rowing and sailing four oceans while raising nearly £300,000 for charities supporting children with rare diseases.   At ENGAGE 2026, Elin Haf will share how resilience, adaptability, and embracing uncertainty can help leaders thrive through rapid change, inspire innovation, and turn ambitious ideas into action. Learn more about Elin Haf and register for ENGAGE here: https://lnkd.in/gkFxm9gZ

AI is moving from pilot projects to real clinical trial workflows. As adoption accelerates, what will matter most in helping organizations scale AI safely and effectively? Stronger data foundations? Clearer governance? Better training for human-in-the-loop oversight? Something else? After attending the ACDM AI Symposium 2026, eClinical Solutions’ Shaun Chard shared his perspective on the progress being made across these areas — and the practical questions sponsors and CROs still need to solve. Read the blog and let us know what you think: https://lnkd.in/gUQBACSW

eClinical's SVP, elluminate Services, Sreekanth Gudapati, joined fellow industry experts last week as a panelist in the Boston event, "AI in Clinical Trials: From Data to Decisions," where he offered his perspective on moving AI from promising concepts into trusted, scalable clinical data workflows. Thank you to Tech in Motion and Vita Global Sciences, a Kelly Company for creating this forum to share and learn from experiences in operationalizing AI for clinical research.

The boundary between clinical trial data and real-world evidence is becoming increasingly blurred. In a new video interview, eClinical Solutions CEO and Co-Founder Raj Indupuri discusses why organizations need infrastructure that can harmonize clinical and real-world data in real time — especially as the industry moves toward a more continuous, data-driven regulatory environment. ▶️ Watch the interview: https://lnkd.in/dteRFJTd

The Gartner® Hype Cycle™ for Life Science R&D, 2026 evaluates technologies across discovery, clinical development, laboratory operations, regulatory affairs, and quality management. But what’s actually worth the hype? Across the market, new solutions promise to improve trial efficiency, strengthen oversight, reduce costs, and help bring therapies to patients faster. As the pace of innovation accelerates, deciding which technologies are worth investment is becoming more complex. In our latest blog, we explore three technologies from the Hype Cycle that are especially relevant to clinical development, along with key considerations for organizations evaluating their adoption strategies. Read more: https://lnkd.in/gRhrd7uE

Regulations surrounding RBQM will continue to evolve, especially as AI advancements accelerate. Is your organization ready for what’s next? Sponsors need integrated, continuous risk management strategies built for today’s regulatory expectations and tomorrow’s demands. Join eClinical's Jason Konn on August 25 for the final webinar in our elluminate Summer Series, as he explores the emerging trends shaping the future of RBQM and how platforms like elluminate RBQM can help organizations operationalize modern risk management. Save your spot: https://lnkd.in/eE5_jGDB

Clinical development is often run as a sequence of handoffs. But what if it could operate more like a continuous learning system? eClinical Solutions Co-Founder and CEO Raj Indupuri recently joined the Life Sciences Today Podcast by Healthcare IT Today to discuss how the industry can move beyond milestone-based, sequential trials and toward a more agile, data-driven model. In the episode, Raj shares his perspective on clinical data chaos, AI in regulated environments, trusted execution, and why sponsors are increasingly treating clinical data as core IP. He also discusses how eClinical is helping clients drive faster cycle times, reduce manual work, and make more agile decisions across clinical development. Listen to the full conversation with Danny Lieberman here: https://lnkd.in/gZexr_kq

Looking for a new role in life sciences? Join the eClinical team! ➡️ View all open positions and apply here: https://lnkd.in/gpixC5XN

The key to building trust for real-world AI adoption? A “glass-box” approach. In a new interview with Applied Clinical Trials, eClinical CEO Raj Indupuri explains why sponsors need the ability to bring their own SOPs, protocols, and governance frameworks into AI systems — and how this could solve AI's black box problem. Watch the full interview with Andy Studna here: https://lnkd.in/dye3x7sQ